NANOS 2018 Literature Review Clinical Papers Neurology. Caroline Tilikete, MD, PhD Hospices Civils de Lyon, University Lyon I Lyon, France
|
|
- Johnathan Shaw
- 6 years ago
- Views:
Transcription
1 NANOS 2018 Literature Review Clinical Papers Neurology Caroline Tilikete, MD, PhD Hospices Civils de Lyon, University Lyon I Lyon, France
2 Nystagmus Effect of Gabapentin/Memantine on the Infantile Nystagmus Syndrome in the Zebrafish Model Bogli SY, Afthinos M, Huang MY. Invest Ophthalmol Vis Sci. 2017;58(7):
3 Nystagmus Magnetic Oculomotor Prosthetics for Acquired Nystagmus. Nachev P, Rose GE, Verity DH, Manohar SG, MacKenzie K, Adams G, et al. Ophthalmology. 2017;124(10):
4 Nystagmus Resolution of periodic alternating nystagmus with amantadine. Lee SH, Lee SY, Choi SM, Kim BC, Kim MK, Kim JS. J Neurol Sci. 2016;364:65-7.
5 Vestibular testing in INO Vestibulo-ocular reflex deficits with medial longitudinal fasciculus lesions. Aw ST, Chen L, Todd MJ, Barnett MH, Halmagyi GM. J Neurol. 2017;264(10): Impaired vestibular responses in internuclear ophthalmoplegia: Association and dissociation. Choi SY, Kim HJ, Kim JS. Neurology Nov 15 Severe deficit of contralesional posterior semicircular canal (SCC) function
6 MOG associated optic neuritis Clinical presentation and prognosis in MOG-antibody disease: a UK study. Jurynczyk M, Messina S, Woodhall MR, Raza N, Everett R, Roca-Fernandez A, et al. Brain. 2017;140(12): Clinical presentation isolated optic neuritis : 55%, bilateral in almost half transverse myelitis: 18% acute disseminated encephalomyelitis-like presentations : 18% Pronostic 16% patients of bad visual acuity (<6/36) in at least 1 eye 7% EDSS > 4 ; 5% EDSS > 6 28% bladder issues, 20% bowel dysfunction and 21% erectile dysfunction Annualized relapse rate 0,2 Decreased with immunosuppression > 3 months
7 MOG associated optic neuritis Etiologies of acute demyelinating optic neuritis: an observational study of 110 patients. Deschamps R, Lecler A, Lamirel C, Aboab J, Gueguen A, Bensa C, et al. Eur J Neurol. 2017;24(6):875 10% ON-MOG What proportion of AQP4-IgGnegative NMO spectrum disorder patients are MOG-IgG positive? Hamid SHM, Whittam D, Mutch K, Linaker S, Solomon T, Das K, et al. J Neurol. 2017;264(10): % MOG-IgG positive
8 MOG associated optic neuritis Optic neuritis in patients with anti-mog antibodies spectrum disorder: MRI and clinical features from a large multicentric cohort in France. Biotti D, Bonneville F, Tournaire E, Ayrignac X, Dalliere CC, Mahieu L, et al. Journal of Neurology. 2017;264(10): optic nerve head swelling Extensive optic nerve T2 hyperintensity with gadolinium enhancement
9 MOG associated optic neuritis MOG-ab as potential markers of severe optic neuritis and subclinical retinal axonal degeneration. Havla J, Kumpfel T, Schinner R, Spadaro M, Schuh E, Meinl E, et al. J Neurol. 2017;264(1): MOG-ab>AQP4-ab Retinal Nerve Fiber Layer May Be Better Preserved in MOG-IgG versus AQP4-IgG Optic Neuritis: A Cohort Study. Stiebel-Kalish H, Lotan I, Brody J, Chodick G, Bialer O, Marignier R, et al. PLoS One. 2017;12(1):e AQP4-ab>MOG-ab
10 Diagnostic MRI criteria for NMOSD Brain lesion distribution criteria distinguish MS from AQP4-antibody NMOSD and MOG-antibody disease. Jurynczyk M, Tackley G, Kong Y, Geraldes R, Matthews L, Woodhall M, et al. J Neurol Neurosurg Psychiatry. 2017;88(2): lesion adjacent to the body of the lateral ventricle and in the inferior temporal lobe 2. subcortical U-fibre lesion 3. Dawson s finger-type lesion sensitivity 90.9% specificity 89.7%
11 Paraneoplastic NMOSD Clinical profile of patients with paraneoplastic neuromyelitis optica spectrum disorder and aquaporin-4 antibodies. Sepulveda M, Sola-Valls N, Escudero D, Rojc B, Baron M, Hernandez-Echebarria L, et al. Multiple sclerosis. 2017: In NMOSD, the risk for cancer is higher in patients who present with brainstem involvement, mainly nausea and vomiting patients older than 45 years, usually male, presenting with extensive transverse myelitis
12 PLEX treatment of NMOSD Short delay to initiate plasma exchange is the strongest predictor of outcome in severe attacks of NMO spectrum disorders. Bonnan M, Valentino R, Debeugny S, Merle H, Ferge JL, Mehdaoui H, et al. J Neurol Neurosurg Psychiatry. 2017
13 Posterior cerebral atrophy (PCA) Consensus classification of posterior cortical atrophy. Crutch SJ, Schott JM, Rabinovici GD, Murray M, Snowden JS, van der Flier WM, et al. Alzheimers Dement. 2017;13(8):870-84
14 Multiple Sclerosis Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria. Thompson AJ, Banwell BL, Barkhof F, Carroll WM, Coetzee T, Comi G, et al. Lancet Neurol In a patient with a typical clinical isolated syndrome (CIS) and fulfilment of clinical or MRI criteria for "dissemination in space" and no better explanation for the clinical presentation, demonstration of CSF-specific oligoclonal bands allows an MS diagnosis to be made without the previously required "dissemination in time. 2. Both symptomatic and asymptomatic MRI lesions can be used for fulfilling MRI criteria for dissemination in space or dissemination in time. 3. In addition to juxtacortical lesions, cortical lesions can also be used to demonstrate dissemination in space requirements. 4. The group also declined to include the presence of optic neuritis pathology in the revised criteria
15 MS Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial. Cadavid D, Balcer L, Galetta S, Aktas O, Ziemssen T, Vanopdenbosch L, et al. Lancet Neurol. 2017;16(3):189-99
New Insights on Optic Neuritis in Young People
Cronicon OPEN ACCESS EC OPHTHALMOLOGY Case Study New Insights on Optic Neuritis in Young People Sergio Carmona 1, Sandra Barbosa 1 and Maria Laura Ortube 2 * 1 Department of Neuro-ophthalmology, Hospital
More informationMRI and differential diagnosis in patients suspected of having MS
Andrea Falini Italy MRI and differential diagnosis in patients suspected of having MS IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Outline of presentation - Diagnostic criteria
More informationPatologie infiammatorie encefaliche e midollari
Patologie infiammatorie encefaliche e midollari Maria Laura Stromillo Department of Medicine, Surgery and Neuroscience Inflammatory disorders of the CNS NMOSD ADEM Multiple Sclerosis Neuro-Myelitis Optica
More informationMagnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome)
J Radiol Sci 2012; 37: 45-50 Magnetic Resonance Imaging of Neuromyelitis Optica (Devic s Syndrome) Chien-Chuan Huang Tai-Yuan Chen Tai-Ching Wu Yu-Kun Tsui Te-Chang Wu Wen-Sheng Tzeng Chien-Jen Lin Department
More informationActualização no diagnóstico e tratamento das doenças desmielinizantes na infância. Silvia Tenembaum
Actualização no diagnóstico e tratamento das doenças desmielinizantes na infância Silvia Tenembaum Acquired CNS inflammatory/demyelinating disorders: Background information More frequent in children than
More informationNEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS
NEW DIAGNOSTIC CRITERIA FOR MULTIPLE SCLEROSIS Jeffrey A. Cohen, MD Director, Experimental Therapeutics Mellen MS Center Neurological Institute Cleveland Clinic 2018 Regional MS Summit 30 June 2018 Disclosures
More informationNeuromyelitis optica (NMO), or Devic s disease, is a rare
Case Report Neuromyelitis Optica (NMO) Abstract NMO is a is a rare entity which involves the central nervous system acting as an inflammatory process by attacking the optic nerve (ON) and longitudinally
More informationMyelitis. Case 2. History. Examination. Mahtab Ghadiri
Case 2 Myelitis Mahtab Ghadiri History A 42-year-old man presented to the emergency department with altered sensation in the lower limbs and difficulty ambulating. He first noted paresthesia in his feet
More informationSawada J, Orimoto R, Misu T, Katayama T, Aizawa H, Asanome A, Takahashi K, Saito T, Anei R, Kamada K, Miyokawa N, Takahashi T, Fujihara K, Hasebe N.
Mult Scler (2014.9) 20(10):1413-1416. A case of pathology-proven neuromyelitis optica spectrum disorder with Sjögren syndrome manifesting aphasia and apraxia due to a localized cerebral white matter lesion.
More informationCOPYRIGHT 2012 THE TRANSVERSE MYELITIS ASSOCIATION. ALL RIGHTS RESERVED
The Transverse Myelitis Association...advocating for those with acute disseminated encephalomyelitis, neuromyelitis optica, optic neuritis and transverse myelitis ACUTE DISSEMINATED ENCEPHALOMYELITIS (ADEM)
More informationAutologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore
Case Reports 26 Autologous Hematopoietic Stem Cell Transplantation for the Treatment of Neuromyelitis Optica in Singapore Koh Yeow Hoay, Pavanni Ratnagopal Abstract Introduction: Neuromyelitis optica (NMO)
More informationHeterogeneity of Demyelinating Disease: Definitions and Overlap Overview
Heterogeneity of Demyelinating Disease: Definitions and Overlap Overview Brian Weinshenker, MD, FRCP(C) Disclosures Royalties related to patent for discovery of NMO-IgG licensed to RSR Ltd; Oxford University
More informationClinical and research application of MRI in diagnosis and monitoring of multiple sclerosis
24-25 February 2016 - Siena, Italy Clinical and research application of MRI in diagnosis and monitoring of multiple sclerosis IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org How
More informationIdiopathic Inflammatory Demyelinating Diseases of the Brainstem
Idiopathic Inflammatory Demyelinating Diseases of the Brainstem 1 A. Rovira-Cañellas, 2 A. Rovira-Gols, 1 J. Sastre-Garriga, 1 C. Auger, 1 J. Munuera, 1 X. Montalban 1 Hospital Vall d Hebron, Barcelona.
More informationWingerchuk et al, Neurol, 2006
Current Understanding of Neuromyelitis Optica Jacqueline A. Leavitt, M.D. Mayo Clinic Rochester, MN I have no financial disclosures 46 y/o F Pain in R temple worse with head movements, resolved in days
More informationPediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study
Pediatric acute demyelinating encephalomyelitis in Denmark: a nationwide population-based study Magnus Spangsberg Boesen November, 2016 Supervisors: P. Born, P. Uldall, M. Blinkenberg, M. Magyari, F. Sellebjerg
More informationNeurological update: MOG antibody disease
https://doi.org/10.1007/s00415-018-9122-2 NEUROLOGICAL UPDATE Neurological update: MOG antibody disease Ray Wynford Thomas 1,2 Anu Jacob 3 Valentina Tomassini 1,2,4 Received: 17 August 2018 / Revised:
More informationMRI in Differential Diagnosis. CMSC, June 2, Jill Conway, MD, MA, MSCE
MRI in Differential Diagnosis CMSC, June 2, 2016 Jill Conway, MD, MA, MSCE Director, Carolinas MS Center Clerkship Director, UNCSOM-Charlotte Campus Charlotte, NC Disclosures Speaking, consulting, and/or
More informationClinical Application of 2017 McDonald Diagnostic Criteria for Multiple Sclerosis
JCN Open Access pissn 1738-6586 / eissn 2005-5013 / J Clin Neurol 2018;14(3):387-392 / https://doi.org/10.3988/jcn.2018.14.3.387 ORIGINAL ARTICLE Clinical Application of 2017 McDonald Diagnostic Criteria
More informationTHE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY
THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY John R. Rinker, II, MD University of Alabama at Birmingham June 2, 2016 DISCLOSURES Research Support: Biogen Idec; Department of
More informationPMH: No medications; Immunizations UTD No hospitalizations or surgeries Speech Delay. Birth Hx: 24 WGA, NICU x6 months
HPI: 6 months of weakness and parathesias- originally in both feet x 2-3 months, then resolved. Now with parathesias and weakness in fingers x 1 week. Seen by podiatrist and given custom in-soles 1 month
More informationMultiple sclerosis in Japan: Nationwide surveys over 30 years
Neurology Asia 28; 13 : 131 143 Multiple sclerosis in Japan: Nationwide surveys over 3 years Jun-ichi Kira, Takaaki Ishizu, Manabu Osoegawa, and The Research Committee of Neuroimmunological Diseases Department
More informationSetting the Scene: Neuromyelitis Optica epidemiology, population variability, subgroups: relapsing/monophasic, Ab +ve/-ve, NMO/SD, treated/untreated
UK Nationally Commissioned NMO team Setting the Scene: Neuromyelitis Optica epidemiology, population variability, subgroups: relapsing/monophasic, Ab +ve/-ve, NMO/SD, treated/untreated Jackie Palace Disclosures
More informationMagnetic Resonance Imaging in the Acquired Demyelinating Disorders: A Pediatric Cohort Study
Journal of Pharmacy and Pharmacology 6 (2018) 20-31 doi: 10.17265/2328-2150/2018.01.003 D DAVID PUBLISHING Magnetic Resonance Imaging in the Acquired Demyelinating Disorders: A Pediatric Cohort Study Santa
More informationResearch Article Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese Multiple Sclerosis
International Scholarly Research Network ISRN Neurology Volume 211, Article ID 9476, 4 pages doi:1.542/211/9476 Research Article Optic Nerve and Spinal Cord Are the Major Lesions in Each Relapse of Japanese
More informationRSR RSR RSR RSR RSR. ElisaRSR AQP4 Ab RSR. Aquaporin-4 Autoantibody Assay Kit
To aid diagnosis of Neuromyelitis Optica (NMO) and NMO spectrum disorder (NMOSD) To confirm diagnosis before initial treatment of patients with demyelinating inflammatory disease NMO, NMOSD and AQP4 Elisa
More informationEndpoints in a treatment trial in NMO: Clinician s view. Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK
Endpoints in a treatment trial in NMO: Clinician s view Anu Jacob Consultant Neurologist The Walton Centre, Liverpool,UK 1 The greatest challenge to any thinker is stating the problem in a way that will
More informationMYELITIS. A Mochan Neurology
MYELITIS A Mochan Neurology ATM MS LETM NMOSD ATM LETM MS NMOSD Acute Transverse Myelitis Longitudinally Extensive Transverse Myelitis Multiple Sclerosis Neuromyelitis Optica Spectrum Disorders ATM ADEM
More informationThe role of anti-aquaporin-4 antibody in Asian patients with multiple sclerosis: Confusions and controversies
Neurology Asia 2007; 12 : 135 139 VIEWS AND REVIEW The role of anti-aquaporin-4 antibody in Asian patients with multiple sclerosis: Confusions and controversies HT Chong, *AG Kermode, CT Tan Department
More informationIsolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis
AJNR Am J Neuroradiol 21:702 706, April 2000 Isolated Demyelinating Syndromes: Comparison of Different MR Imaging Criteria to Predict Conversion to Clinically Definite Multiple Sclerosis Mar Tintoré, Alex
More informationCHAIR SUMMIT 7TH ANNUAL #CHAIR2014. Master Class for Neuroscience Professional Development. September 11 13, Westin Tampa Harbour Island
#CHAIR2014 7TH ANNUAL CHAIR SUMMIT Master Class for Neuroscience Professional Development September 11 13, 2014 Westin Tampa Harbour Island Sponsored by #CHAIR2014 Use of MRI in Clinical Decision- Making
More informationDiagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria
Diagnosis of multiple sclerosis: 2017 revisions of the McDonald criteria Alan J Thompson, Brenda L Banwell, Frederik Barkhof, William M Carroll, Timothy Coetzee, Giancarlo Comi, Jorge Correale, Franz Fazekas,
More informationDisease of Myelin. Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019
Disease of Myelin Reid R. Heffner, MD Distinguished Teaching Professor Emeritus Department of Pathology and Anatomy January 9, 2019 1 I HAVE NO CONFLICTS OF INTEREST OR DISCLOSURES TO DECLARE. I HAVE NO
More informationMyelitis. Myelitis. Multiple Sclerosis (MS) Acute demyelinating syndrome (ADS) Indictions for spinal cord MRI in MS.
Myelitis Myelitis Majda M Thurnher Professor of Radiology Medical University of Vienna University Hospital Vienna Department of Biomedical Imaging and Image-Guided Therapy Vienna Austria Acute demyelinating
More informationMyelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal Detachment
doi: 10.2169/internalmedicine.9840-17 Intern Med 57: 3307-3312, 2018 http://internmed.jp CASE REPORT Myelin Oligodendrocyte Glycoprotein-IgG-positive Recurrent Bilateral Optic Papillitis with Serous Retinal
More informationHot Topics Multiple Sclerosis. Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018
Hot Topics Multiple Sclerosis Natalie Parks, MD, FRCPC Assistant Professor, Dalhousie University June 27, 2018 Disclosures Natalie Parks has received compensation from Biogen, EMD Serono, Roche, and Sanofi
More informationClinically isolated syndromes (CIS) may
RECOGNIZING AND MANAGING THE CLINICALLY ISOLATED SYNDROME* Steven L. Galetta, MD ABSTRACT Clinically isolated demyelinating syndromes, such as optic neuritis, transverse myelitis, and brain-stem disorders,
More informationMultiple sclerosis. Tünde Csépány MD. PhD
Multiple sclerosis Tünde Csépány MD. PhD. 11. 19. 2008. Multiple Sclerosis Approximately 350 000 people in the United States are affected by MS Prevalence strongly dependent on latitude (25-224/100 000
More informationInteractive Cases: Demyelinating Diseases and Mimics. Disclosures. Case 1 25 yo F with nystagmus; look for tumor 4/14/2017
Interactive Cases: Demyelinating Diseases and Mimics Disclosures None Brad Wright, MD 27 March 2017 Case 1 25 yo F with nystagmus; look for tumor What do you suspect? A. Demyelinating disease B. Malignancy
More informationCURRICULUM VITAE. Young Eun Huh, MD, PhD
CURRICULUM VITAE Young Eun Huh, MD, PhD NATIONALITY: South Korea LICENSURE or CERTIFICATION: 2004 Medical license (83710) 2009 Certificates of competency, neurology (1230) EDUCATION and TRAINING: 2004
More informationGILENYA (fingolimod) oral capsule
GILENYA (fingolimod) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy Coverage
More informationTECFIDERA (dimethyl fumarate) oral capsule
TECFIDERA (dimethyl fumarate) oral capsule Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationProvider Led Entity. CDI Quality Institute PLE Multiple Sclerosis (MS) AUC
Provider Led Entity CDI Quality Institute PLE Multiple Sclerosis (MS) AUC Appropriateness of advanced imaging procedures* in patients with the following clinical presentations or diagnoses: 09/04/2018
More informationPeripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases
Peripheral neuropathies, neuromuscular junction disorders, & CNS myelin diseases Peripheral neuropathies according to which part affected Axonal Demyelinating with axonal sparing Many times: mixed features
More information1st interactive course in MS advanced managment
6-7 December - Toronto, Canada 1st interactive course in MS advanced managment IMPROVING THE PATIENT S LIFE THROUGH MEDICAL EDUCATION www.excemed.org Liesly Lee Sunnybrook Health Sciences Centre. Department
More information1 MS Lesions in T2-Weighted Images
1 MS Lesions in T2-Weighted Images M.A. Sahraian, E.-W. Radue 1.1 Introduction Multiple hyperintense lesions on T2- and PDweighted sequences are the characteristic magnetic resonance imaging (MRI) appearance
More informationHelpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI
Helpful Information for evaluation of new neurological symptoms in patients receiving TYSABRI This information is provided as an educational resource for healthcare providers and should be considered current
More informationIndex. Note: Page numbers of article titles are in boldface type.
Index Note: Page numbers of article titles are in boldface type. A Acetazolamide, in idiopathic intracranial hypertension, 49 52, 60 Angiography, computed tomography, in cranial nerve palsy, 103 107 digital
More informationThe use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica
Neurology Asia 2014; 19(4) : 375 385 The use of AQP4-antibody testing in diagnosis Thai patients with neuromyelitis optica 1,2 Sasitorn Siritho MD, 3 Metha Apiwattanakul MD, 1 Naraporn Prayoonwiwat MD
More informationPATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M / F Year Month Day
Applicant must be covered on an Alberta Government sponsored drug program. Page 1 of 6 PATIENT INFORMATION: Patient Surname First Name Middle Initial Sex Date of Birth Alberta Personal Health Number M
More informationFatigue And Beyond How Vision Captures Disease in MS
Fatigue And Beyond How Vision Captures Disease in MS Salim Chahin, MD Fellow Multiple Sclerosis University of Pennsylvania Outline Introduction. Visual function testing disease outcomes. Optical Coherence
More informationMRI Imaging of Neuromyelitis Optica
July 2009 MRI Imaging of Neuromyelitis Optica Jenna Nolan, Harvard Medical School Year III Gillian Lieberman, MD Our Patient: Initial Presentation J.H. is a 29 year-old woman who presents with acute vision
More informationPatient-reported outcomes, biomarkers and novel methodologies, and their role in the development of new multiple sclerosis medicines
Patient-reported outcomes, biomarkers and novel methodologies, and their role in the development of new multiple sclerosis medicines Frank Dahlke MD, Novartis Pharma AG on behalf of efpia 1 Patient Reported
More informationTitle: Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases.
Author's response to reviews Title: Recurrent myelitis after allogeneic stem cell transplantation. Report of two cases. Authors: Martin Voss (Martin.Voss@kgu.de) Felix Bischof (Felix.Bischof@uni-tuebingen.de)
More informationDemyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow
Demyelinating Diseases: Multiple Sclerosis January 10, 2018 Dr. Ostrow Reading: Robbins & Cotran, 9 th edition, pp 1283-1286 Robbins Basic Pathology, 9 th edition, 832-835 Overview: Grossly, myelin is
More informationSalintip Kunadison MD, Chaiwiwat Tungkasereerak MD, Surin Saetang MD, Pawut Mekawichai MD
Neurology Asia 2018; 23(1) : 55 59 Comparison of clinical features between aquaporin-4 antibody seropositive and seronegative patients in neuromyelitis optica and neuromyelitis optica spectrum disorder
More informationORIGINAL CONTRIBUTION. Multiple Sclerosis That Is Progressive From the Time of Onset
ORIGINAL CONTRIBUTION Multiple Sclerosis That Is Progressive From the Time of Onset Clinical Characteristics and Progression of Disability P. B. Andersson, MBChB, DPhil; E. Waubant, MD; L. Gee, MPH; D.
More informationMRI in MS. MRI in multiple sclerosis. MS T2 Lesions: Pathology. Brain lesions Morphology Matters. Sagittal FLAIR Morphology Matters
MRI in multiple sclerosis MRI in MS Rohit Bakshi, MD, MA Breakstone Professor of Neurology & Radiology Director, Laboratory for Neuroimaging Research Senior Neurologist, MS Center Brigham & Women s Hospital
More informationMRI features and anti-aqp4 antibody status in Idiopathic inflammatory demyelinating CNS disease (IIDCD) in Thai patients
Neurology Asia 2013; 18(1) : 73 81 MRI features and anti-aqp4 antibody status in Idiopathic inflammatory demyelinating CNS disease (IIDCD) in Thai patients 1 Naraporn Prayoonwiwat MD, 2 Orasa Chawalparit
More informationProfessor Yasser Metwally. Neuromyelitis optica. EPIDEMIOLOGY
180 Professor Yasser Metwally Neuromyelitis optica www.yassermetwally.com N EPIDEMIOLOGY Afro-Caribbean, and South American descent implying underlying genetic mechanisms in the expression of demyelinating
More informationSoliris in NMOSD Phase 3 PREVENT Study Topline Results September 24, 2018
Soliris in NMOSD Phase 3 PREVENT Study Topline Results September 24, 2018 Forward-Looking Statements This presentation contains forward-looking statements within the meaning of the Private Securities Litigation
More informationOcular Oscillations and Transient Oscillopsia in Neuromyelitis Optica
Elmer ress Case Report J Neurol Res. 2014;4(5-6):145-149 Ocular Oscillations and Transient Oscillopsia in Neuromyelitis Optica Nitin Nema a, c, Abha Verma a, Urvija Choudhary a, Pramod Sakhi b Abstract
More informationORIGINAL CONTRIBUTION. Painful Tonic Spasm in Neuromyelitis Optica. Incidence, Diagnostic Utility, and Clinical Characteristics
ORIGINAL CONTRIBUTION Painful Tonic Spasm in Neuromyelitis Optica Incidence, Diagnostic Utility, and Clinical Characteristics Sung-Min Kim, MD; Min Jin Go, MS; Jung-Joon Sung, MD, PhD; Kyung Seok Park,
More informationNIH Public Access Author Manuscript Arch Neurol. Author manuscript; available in PMC 2012 July 1.
NIH Public Access Author Manuscript Published in final edited form as: Arch Neurol. 2011 July ; 68(7): 870 878. doi:10.1001/archneurol.2011.34. Beneficial Plasma Exchange Response in CNS Inflammatory Demyelination
More informationNeurophysiology in diagnosis and monitoring of MS
ISTITUTO SCIENTIFICO UNIVERSITARIO SAN RAFFAELE MS Academia Amsterdam - October 18, 2011 Neurophysiology in diagnosis and monitoring of MS Letizia Leocani Dep.t of Neurology, Clin. Neurophysiol. and Neurorehabilitation
More informationMRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis. E.W. Radue K. Bendfeldt Till Sprenger
MRI in Multiple Sclerosis Features of Cerebral Atrophy with special focus on Multiple Sclerosis E.W. Radue K. Bendfeldt Till Sprenger Medical Image Analysis Center University Hospital Basel www. miac.ch
More informationMRI dynamics of brain and spinal cord in progressive multiple sclerosis
J7ournal of Neurology, Neurosurgery, and Psychiatry 1 996;60: 15-19 MRI dynamics of brain and spinal cord in progressive multiple sclerosis 1 5 D Kidd, J W Thorpe, B E Kendall, G J Barker, D H Miller,
More informationMultiple sclerosis. Tünde Csépány MD. PhD. 08. November 2017.
Multiple sclerosis Tünde Csépány MD. PhD. 08. November 2017. Multiple Sclerosis Approximately 350 000 people in the United States are affected by MS Prevalence strongly dependent on latitude (25-224/100
More informationTHE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY
THE NATURAL HISTORY OF MS: DIAGNOSIS, CLINICAL COURSE, AND EPIDEMIOLOGY John R. Rinker II, MD University of Alabama at Birmingham Birmingham VA Medical Center May 29, 2014 DISCLOSURES Salary/Research:
More informationAUBAGIO (teriflunomide) oral tablet
AUBAGIO (teriflunomide) oral tablet Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Pharmacy
More informationThe Etiological Spectrum of Acute Sensory Myelitis
Open Access pissn 1738-6586 / eissn 2005-5013 / J Clin Neurol 2015;11(3):227-233 / http://dx.doi.org/10.3988/jcn.2015.11.3.227 ORIGINAL ARTICLE Jae-Won Hyun a,c Jee Young Kim b Kyung Gyu Choi a Ho Jin
More informationBRAINSTEM SYNDROMES OF NEURO-OPHTHALMOLOGICAL INTEREST
BRAINSTEM SYNDROMES OF NEURO-OPHTHALMOLOGICAL INTEREST Steven L. Galetta, MD NYU Langone Medical Center New York, NY I. Anatomical Considerations The brain stem is about the size of a fat forefinger and
More informationSpinal cord MR imaging in Multiple Sclerosis
43ème CONGRÈS ANNUEL de la Société Française de NeuroRadiologie 30 mars au 1 er avril 2016 Novotel Paris Tour Eiffel Spinal cord MR imaging in Multiple Sclerosis Àlex Rovira Unitat de Neurorradiología.
More informationSevere visual loss due to optic neuritis (ON) is the most
Ocular Oscillations in the Neuromyelitis Optica Spectrum Rabih Hage, Jr, MD, Harold Merle, MD, Séverine Jeannin, MD, Philippe Cabre, MD Abstract: Four French West Indian women complained of oscillopsia
More informationORIGINAL CONTRIBUTION. Long-term Follow-up of Acute Partial Transverse Myelitis
ORIGINAL CONTRIBUTION Long-term Follow-up of Acute Partial Transverse Myelitis Bertrand Bourre, MD; Hélène Zéphir, MD; Jean-Claude Ongagna, CRA; Charlotte Cordonnier, MD, PhD; Nicolas Collongues, MD; Stephanie
More informationBlood Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability
The Journal of International Medical Research 2012; 40: 1483 1491 Blood Brain Barrier Disruption is More Severe in Neuromyelitis Optica than in Multiple Sclerosis and Correlates with Clinical Disability
More informationPearls, Pitfalls and Advances in Neuro-Ophthalmology
Pearls, Pitfalls and Advances in Neuro-Ophthalmology Nancy J. Newman, MD Emory University Atlanta, GA Consultant for Gensight Biologics, Santhera Data Safety Monitoring Board for Quark AION Study Medical-legal
More informationMULTIPLE SCLEROSIS - REVIEW AND UPDATE
MULTIPLE SCLEROSIS - REVIEW AND UPDATE Luka Vlahovic, MD Neuroimmunology/Multiple Sclerosis Creighton University Medical Center MS is primary demyelinating disease of the central nervous system. MS is
More informationNeurological Assessment for Multiple Sclerosis and Extended Disability Scale Score
Neurological Assessment for Multiple Sclerosis and Extended Disability Scale Score This section should only be completed by a neurologist or MD / ROD (Medical Doctor / Resident on Duty) involved in the
More informationRole of MRI in acute disseminated encephalomyelitis
Original Research Article Role of MRI in acute disseminated encephalomyelitis Shashvat Modiya 1*, Jayesh Shah 2, C. Raychaudhuri 3 1 1 st year resident, 2 Associate Professor, 3 HOD and Professor Department
More informationMultiple Sclerosis (MS) is a
The role of interferon beta in multiple sclerosis management David J Rog MRCP, John P Mottershead MRCP, Greater Manchester Neurosciences Centre, Hope Hospital, Stott Lane, Manchester, M6 8HD SPL Multiple
More informationProgram Highlights. A multidisciplinary AAN working group identified areas for improvement in the diagnosis and management of patients with MS
CasePerspectives: Illuminating Dark Pathways in Complex MS Cases Program Highlights Stephen Krieger, MD Associate Professor of Neurology Corinne Goldsmith Dickinson Center for MS Director, Neurology Residency
More informationThe Multiple Sclerosis Lesion Checklist
The Multiple Sclerosis Lesion Checklist A clinician s guide to evaluating brain MRI in a patient with improbable multiple sclerosis. By Ilya Kister, MD, FAAN Paraphrasing W.B. Matthews about dizziness,
More informationOptic Neuritis and Multiple Sclerosis
Part I Optic Nerve Chapter 1 Optic Neuritis and Multiple Sclerosis Edward J. Atkins, Valérie Biousse, Nancy J. Newman 1 Core Messages Idiopathic optic neuritis, an isolated inflammatory optic neuropathy
More informationCognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis. Background
Cognitive Impairment and Magnetic Resonance Changes in Multiple Sclerosis Victoria A Levasseur 1,2, Samantha Lancia 1, Gautam Adusumilli 1, Zach Goodman 1, Stuart D. Cook 3, Diego Cadavid 4, Robert T.
More informationCNS demyelination and quadrivalent HPV vaccination
SHORT REPORT Multiple Sclerosis 2009; 15: 116 119 CNS demyelination and quadrivalent HPV vaccination I Sutton 1,2, R Lahoria 3, IL Tan 1, P Clouston 4 and MH Barnett 2,3 Vaccination is generally considered
More informationNeuromyelitis Optica Spectrum Disorder (NMOSD): Brain MRI findings in patients at our institution and literature review.
Neuromyelitis Optica Spectrum Disorder (NMOSD): Brain MRI findings in patients at our institution and literature review. Poster No.: C-0817 Congress: ECR 2014 Type: Educational Exhibit Authors: G. I. MICHELIN,
More informationMEDIA BACKGROUNDER. Multiple Sclerosis: A serious and unpredictable neurological disease
MEDIA BACKGROUNDER Multiple Sclerosis: A serious and unpredictable neurological disease Multiple sclerosis (MS) is a complex chronic inflammatory disease of the central nervous system (CNS) that still
More informationPRIMARY DISEASES OF MYELIN
PRIMARY DISEASES OF MYELIN Acquired forms - Characterized by preferential damage to previously normal myelin with relative preservation of axons and include: 1. Immune-mediated injury, such as multiple
More informationThe Role of MRI in Multiple Sclerosis
September 2006 The Role of MRI in Multiple Sclerosis David Cochran, Harvard Medical School Year IV Meet our patient WM 49yoF presents to Multiple Sclerosis Clinic for follow-up regarding worsening symptoms
More informationTransverse Myelitis and Myelopathy in the VA system: Etiology and Epidemiology
Transverse Myelitis and Myelopathy in the VA system: Etiology and Epidemiology Stacey L. Clardy MD PhD Staff Neurologist, Salt Lake City VA Assistant Professor of Neurology, University of Utah Director,
More informationClinical differences between young and older patients with optic neuritis
Original Article Page 1 of 5 Clinical differences between young and older patients with optic neuritis Wenjing Luo 1 *, Qiu-Shui Huang 2 *, Jian-Feng He 2, Min Han 1, Bo Liu 1, Yi Du 2 1 The Cadre Ward
More informationBrainstorming the Case: An unusual presentation of autoimmune encephalitis
Brainstorming the Case: An unusual presentation of autoimmune encephalitis Alyssa Tilly, MD, LeeAnne Flygt, MD, MA, Ashley Sutton, MD UNC Chapel Hill Department of Pediatrics Disclosure of Financial Relationships
More informationOcrevus (ocrelizumab)
Ocrevus (ocrelizumab) Policy Number: 5.01.629 Last Review: 04/2018 Origination: 05/2017 Next Review: 04/2019 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide coverage for Ocrevus
More informationNeuromyelitis Optica Spectrum Disorder (NMOSD)
Neuromyelitis Optica Spectrum Disorder (NMOSD) Neuromyelitis Optica Spectrum Disorder (NMOSD) is a rare relapsing autoimmune disorder that preferentially causes inflammation in the optic nerve and spinal
More informationDiagnostic Criteria, Clinical Courses, and Rating Scales in MS
Diagnostic Criteria, Clinical Courses, and Rating Scales in MS Introduction and Objectives Introduction This module will focus on diagnostic tools utilized in randomized clinical trials (RCTs) in MS. Diagnostic
More informationMULTIPLE SCLEROSIS PROFILE
MULTIPLE SCLEROSIS PROFILE What is Multiple Sclerosis? Multiple sclerosis (MS) is a chronic, inflammatory disease of unknown etiology that involves an immune-mediated attack on the central nervous system
More informationUsefulness of optical coherence tomography to distinguish optic neuritis associated with AQP4 or MOG in neuromyelitis optica spectrum disorders
655264TAN0010.1177/1756285616655264Therapeutic Advances in Neurological DisordersEH Martinez-Lapiscina, M Sepulveda research-article2016 Therapeutic Advances in Neurological Disorders Letter to the Editor
More informationClinical Case Study Discussion of Demyelinating Diseases. Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011
Clinical Case Study Discussion of Demyelinating Diseases Mirela Cerghet, MD, PhD Henry Ford Hospital August 6, 2011 No financial disclosures Will discuss use of non-fda approved medication CONTENT Case
More informationAnaesthesia recommendations for patients suffering from Neuromyelitis optica spectrum disorder
orphananesthesia Anaesthesia recommendations for patients suffering from Neuromyelitis optica spectrum disorder Disease name: Neuromyelitis optica spectrum disorder ICD 10: G36.0 Synonyms: Devic's Disease,
More information